BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34344308)

  • 1. Delayed reversibility of complete atrioventricular block: cardio-biliary reflex after alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Fang S; Gao L; Yang F; Gong YJ
    BMC Cardiovasc Disord; 2021 Aug; 21(1):372. PubMed ID: 34344308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Axelsson A; Weibring K; Havndrup O; Kelbæk H; Jørgensen E; Helqvist S; Iversen K; Køber L; Bundgaard H; Jensen MK
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):214-21. PubMed ID: 24662414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy in the Young and the Elderly.
    Liebregts M; Steggerda RC; Vriesendorp PA; van Velzen H; Schinkel AF; Willems R; van Cleemput J; van den Berg MP; Michels M; ten Berg JM
    JACC Cardiovasc Interv; 2016 Mar; 9(5):463-9. PubMed ID: 26965935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Vermaete I; Dujardin K; Stammen F
    Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
    [No Abstract]   [Full Text] [Related]  

  • 6. Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
    Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Groch L; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Kuhn H
    Can J Cardiol; 2013 Nov; 29(11):1415-21. PubMed ID: 23927866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic phase improvements in electrocardiographic and echocardiographic manifestations of left ventricular hypertrophy after alcohol septal ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Matsuda J; Kitamura M; Takayama M; Imori Y; Shibuya J; Kubota Y; Sangen H; Nakamura S; Takano H; Asai K; Shimizu W
    Heart Vessels; 2018 Mar; 33(3):246-254. PubMed ID: 28965135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Five cases of complete atrioventricular block induced by bending forward: unusual but not unique.
    Saal DP; Thijs RD; Bootsma M; Brignole M; van Dijk JG
    Europace; 2021 Sep; 23(9):1487-1492. PubMed ID: 33693701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and predictors of late complete heart block after alcohol septal ablation treatment of hypertrophic obstructive cardiomyopathy.
    Schuller JL; Zipse MM; Krantz MJ; Blaker B; Salcedo E; Groves BM; Messenger JC; Beaty B; Sauer WH
    J Interv Cardiol; 2015 Feb; 28(1):90-7. PubMed ID: 25689552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Patients With Hypertrophic Obstructive Cardiomyopathy and Pacemaker Implanted After Alcohol Septal Ablation.
    Veselka J; Liebregts M; Cooper R; Faber L; Januska J; Kashtanov M; Tesarkova KH; Hansen PR; Seggewiss H; Shloydo E; Popov K; Hansvenclova E; Bonaventura J; Berg JT; Stables RH; Polakova E
    JACC Cardiovasc Interv; 2022 Oct; 15(19):1910-1917. PubMed ID: 36202559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
    Wojtarowicz A; Kornacewicz-Jach Z
    Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of pacemaker implantation at follow-up after reversible high-degree sinus node dysfunction or atrioventricular block.
    Habbout A; Sagnard A; Pommier T; Didier R; Garnier F; Fichot M; Bertaux G; Laurent G; Guenancia C
    Pacing Clin Electrophysiol; 2023 Aug; 46(8):994-1002. PubMed ID: 37319108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Kazmierczak J; Kornacewicz-Jach Z; Kisly M; Gil R; Wojtarowicz A
    Heart; 1998 Sep; 80(3):257-62. PubMed ID: 9875085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
    Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
    Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term outcome and related predictors of alcohol septal ablation for patients with hypertrophic obstructive cardiomyopathy].
    Liu R; Qiao SB; Hu FH; Yang WX; Yuan JS; Cui JG
    Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Sep; 44(9):771-776. PubMed ID: 27667275
    [No Abstract]   [Full Text] [Related]  

  • 16. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of alcohol septal ablation in adolescents and young adults with hypertrophic obstructive cardiomyopathy.
    Lawin D; Lawrenz T; Radke K; Stellbrink C
    Clin Res Cardiol; 2022 Feb; 111(2):207-217. PubMed ID: 34817646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Disparities in Clinical Outcome After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy in the Chinese Han Population: A Cohort Study.
    Wang Y; Zhao HW; Wang CF; Meng QK; Cui CS; Zhang XJ; Zhu Y; Fan CY; Luo DF; Chen BJ; Luan B; Hou AJ
    Heart Lung Circ; 2020 Dec; 29(12):1856-1864. PubMed ID: 32611501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
    Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
    Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rescue alcohol septal ablation in sepsis with multiorgan failure.
    Barwad PW; Ramakrishnan S; Seth S; Bhargava B
    Indian Heart J; 2012; 64(6):588-90. PubMed ID: 23253412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.